46 results
8-K
EX-99.1
VRNA
Verona Pharma Plc
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
-19 pandemic, and conflicts such as the Russia-Ukraine conflict, which has and may continue to adversely impact our business. These and other
8-K
EX-99.1
VRNA
Verona Pharma Plc
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
epidemics or pandemics like the COVID-19 pandemic, and conflicts such as the Russia-Ukraine conflict, which has and may continue to adversely impact our
8-K
EX-99.1
qlicw0g7136s lxp
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
EX-99.1
wzh1vvvmpox
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
8-K
EX-99.1
5dva99i9c9mqv
9 May 23
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
6:13am
8-K
003bnm 46bnmu
20 Dec 22
Regulation FD Disclosure
6:02am
8-K
EX-99.1
e29kp01mptx s2qvoy2
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am
8-K
fndnh
11 Aug 22
Other Events
5:46pm
8-K
vm7ceefx jw6xzv
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
EX-99.1
jhzhlr2yju7fhdy
9 Aug 22
Verona Pharma Reports Second Quarter 2022 Financial Results and Provides Corporate Update
8:17am
8-K
EX-99.1
efa07uzft 8odc3
3 May 22
Verona Pharma Reports First Quarter 2022 Financial Results and Provides Corporate Update
6:11am